Schenelle Dayna Dlima

Schenelle Dayna Dlima

Auto-generated profile, based on publicly available information

Schenelle Dayna Dlima

School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2024 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
SDSchenelle Dayna Dlima
Schenelle Dayna Dlima
AHAlex Hall
Alex Hall
AAAbodunrin Quadri Aminu
Abodunrin Quadri Aminu
AAAsangaedem Akpan
Asangaedem Akpan
CTChris Todd
Chris Todd
EVEmma R L C Vardy
Emma R L C Vardy
Frailty is a complex, age-related clinical condition that involves multiple contributing factors and raises the risk of adverse outcomes in older people. Given global population ageing trends, the growing prevalence and incidence of frailty pose significant challenges to health and social care systems in both high-income and lower-income countries. In this review, we highlight the disproportionate representation of research on frailty screening and management from high-income countries, despite how lower-income countries are projected to have a larger share of older people aged ≥60. However, more frailty research has been emerging from lower-income countries in recent years, paving the way for more context-specific guidelines and studies that validate frailty assessment tools and evaluate frailty interventions in the population. We then present further considerations for contextualising frailty in research and practice in lower-income countries. First, the heterogeneous manifestations of frailty call for research that reflects different geographies, populations, health systems, community settings and policy priorities; this can be driven by supportive collaborative systems between high-income and lower-income countries. Second, the global narrative around frailty and ageing needs re-evaluation, given the negative connotations linked with frailty and the introduction of intrinsic capacity by the World Health Organization as a measure of functional reserves throughout the life course. Finally, the social determinants of health as possible risk factors for frailty in lower-income countries and global majority populations, and potential socioeconomic threats of frailty to national economies warrant proactive frailty screening in these populations.

18 July 2022 in JMIR Bioinformatics and Biotechnology
Verified
Journal Article
Open access
SDSchenelle Dayna Dlima
Schenelle Dayna Dlima
SSSantosh Shevade
Santosh Shevade
SMSonia Rebecca Menezes
Sonia Rebecca Menezes
AGAakash Ganju
Aakash Ganju
Background: Digital phenotyping is the real-time collection of individual-level active and passive data from users in naturalistic and free-living settings via personal digital devices, such as mobile phones and wearable devices. Given the novelty of research in this field, there is heterogeneity in the clinical use cases, types of data collected, modes of data collection, data analysis methods, and outcomes measured. Objective: The primary aim of this scoping review was to map the published research on digital phenotyping and to outline study characteristics, data collection and analysis methods, machine learning approaches, and future implications. Methods: We utilized an a priori approach for the literature search and data extraction and charting process, guided by the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews). We identified relevant studies published in 2020, 2021, and 2022 on PubMed and Google Scholar using search terms related to digital phenotyping. The titles, abstracts, and keywords were screened during the first stage of the screening process, and the second stage involved screening the full texts of the shortlisted articles. We extracted and charted the descriptive characteristics of the final studies, which were countries of origin, study design, clinical areas, active and/or passive data collected, modes of data collection, data analysis approaches, and limitations. Results: A total of 454 articles on PubMed and Google Scholar were identified through search terms associated with digital phenotyping, and 46 articles were deemed eligible for inclusion in this scoping review. Most studies evaluated wearable data and originated from North America. The most dominant study design was observational, followed by randomized trials, and most studies focused on psychiatric disorders, mental health disorders, and neurological diseases. A total of 7 studies used machine learning approaches for data analysis, with random forest, logistic regression, and support vector machines being the most common. Conclusions: Our review provides foundational as well as application-oriented approaches toward digital phenotyping in health. Future work should focus on more prospective, longitudinal studies that include larger data sets from diverse populations, address privacy and ethical concerns around data collection from consumer technologies, and build “digital phenotypes” to personalize digital health interventions and treatment plans.

3 May 2025 in The Journal of Frailty & Aging
Verified
Journal Article
Open access
SDSchenelle Dayna Dlima
Schenelle Dayna Dlima
DHDanielle Harris
Danielle Harris
AAAbodunrin Quadri Aminu
Abodunrin Quadri Aminu
AHAlex Hall
Alex Hall
CTChris Todd
Chris Todd
EVEmma Rlc Vardy
Emma Rlc Vardy
A frailty index (FI) is a frailty assessment tool calculated as the proportion of the number of health-related deficits an individual has to the total number of variables in the index. Routinely collected clinical and administrative data can be used as sources of deficits to automatically calculate FIs. This scoping review aimed to evaluate the current research landscape on routine data-based FIs. We searched seven databases to find literature published in 2013-2023. Main inclusion criteria were original research articles on FIs constructed from routine data, with deficits in at least two of the following categories: "symptoms/signs", "laboratory values", "diseases", "disabilities", and "others". From 7526 publications screened, 218 were included. Studies were primarily from North America (47.7 %), conducted in the community (35.3 %), and used routine data-based FIs for risk stratification (51.4 %). FIs were calculated using various routine data sources; however, most were initially developed and validated using hospital records. We noted geographical differences in study settings and routine data sources. We identified 611 unique deficits comprising these FIs. Most were either "diseases" (34.4 %) or "symptoms/signs" (32.1 %). Routine data-based FIs are feasible and valid risk stratification tools, but research is confined to high-income countries, their routine adoption is slow, and deficits comprising these FIs emphasise a reactive and overtly medical approach in addressing frailty. Future directions include exploring the feasibility and applicability of using routine databases for frailty assessment in lower- and middle-income countries, and leveraging non-clinical routine data through data linkages to proactively identify and manage frailty.

16 May 2022 in JMIR Preprints
Verified
Preprint
Open access
SDSchenelle Dayna Dlima
Schenelle Dayna Dlima
SSSantosh Shevade
Santosh Shevade
SMSonia Rebecca Menezes
Sonia Rebecca Menezes
AGAakash Ganju
Aakash Ganju
BACKGROUND Digital phenotyping is the real-time collection of individual-level active and passive data from users in naturalistic and free-living settings via personal digital devices, such as mobile phones and wearable devices. Given the novelty of research in this field, there is heterogeneity in the clinical use cases, types of data collected, modes of data collection, data analysis methods, and outcomes measured. OBJECTIVE The primary aim of this scoping review was to map the published research on digital phenotyping and to outline study characteristics, data collection and analysis methods, machine learning approaches, and future implications. METHODS We utilized an a priori approach for the literature search and data extraction and charting process, guided by the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews). We identified relevant studies published in 2020, 2021, and 2022 on PubMed and Google Scholar using search terms related to digital phenotyping. The titles, abstracts, and keywords were screened during the first stage of the screening process, and the second stage involved screening the full texts of the shortlisted articles. We extracted and charted the descriptive characteristics of the final studies, which were countries of origin, study design, clinical areas, active and/or passive data collected, modes of data collection, data analysis approaches, and limitations. RESULTS A total of 454 articles on PubMed and Google Scholar were identified through search terms associated with digital phenotyping, and 46 articles were deemed eligible for inclusion in this scoping review. Most studies evaluated wearable data and originated from North America. The most dominant study design was observational, followed by randomized trials, and most studies focused on psychiatric disorders, mental health disorders, and neurological diseases. A total of 7 studies used machine learning approaches for data analysis, with random forest, logistic regression, and support vector machines being the most common. CONCLUSIONS Our review provides foundational as well as application-oriented approaches toward digital phenotyping in health. Future work should focus on more prospective, longitudinal studies that include larger data sets from diverse populations, address privacy and ethical concerns around data collection from consumer technologies, and build “digital phenotypes” to personalize digital health interventions and treatment plans.

28 July 2026 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
SDSchenelle Dayna Dlima
Schenelle Dayna Dlima
AAAbodunrin Quadri Aminu
Abodunrin Quadri Aminu
AHAlex Hall
Alex Hall
CTChris Todd
Chris Todd
EVEmma Rlc Vardy
Emma Rlc Vardy
Introduction: Frailty is a clinical syndrome associated with greater risk of functional limitations and dependency. However, older people with or at risk of frailty who live at home can still lead fulfilling lives, engage with their community, and maintain a good quality of life, that is, age in place well. To support this and prevent resource-intensive care use, this expert consultation survey aimed to identify proxy indicators that capture ageing-in-place experiences in community-dwelling older people with frailty. Methods: Using a modified Delphi approach, two survey rounds were conducted to build consensus on proxy ageing-in-place indicators in relation to frailty. Eighty-nine indicators were extracted from a rapid literature review and grouped into five themes: Personal Characteristics of Older People , Place , Social Networks , Support , and Technology . Eighteen experts in geriatric care and gerontology rated indicators for importance for ageing-in-place and feasibility of routine measurement. Consensus for importance and feasibility was defined as mean scores ≥ 4.0 (scale 1–5), suggesting indicators were extremely/very important for ageing-in-place and extremely/very feasible to measure routinely. Public contributors, who were experts by lived experiences of frailty and ageing-in-place, also reviewed the indicators and survey findings. Results: Only four proxy indicators reached consensus for importance and feasibility: “physical performance and mobility”, “multimorbidity”, “sensory function”, and “pressure ulcers” (all Personal Characteristics ). Twenty-seven indicators were extremely/very important for ageing-in-place but not as feasible to measure routinely (17 related to Personal Characteristics , 4 to Social Networks , and 3 to Place and Support ). Only five indicators (the four consensus indicators and “polypharmacy”) were extremely/very feasible to measure routinely. No technology-related indicators were extremely/very important or feasible to measure routinely. Mean scores of few indicators differed by experts’ occupations and areas of expertise. Public contributors generally agreed with the survey results but highlighted the importance of technology-related indicators (particularly “digital literacy”) and more integrated care records to support targeted care. Conclusions: This study lays the foundation for developing standardised proxy ageing-in-place indicators to monitor how older people with or at risk of frailty are living in their homes and communities. Future directions include assessing feasibility of capturing non-clinical indicators routinely; applying these indicators to guide personalised targeted interventions; and leveraging technology-related indicators to improve digital inclusion and literacy in older people to support ageing-in-place.

29 October 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JGJaheeda Gangannagaripalli
Jaheeda Gangannagaripalli
SASaima Ahmed
Saima Ahmed
APAmelia Parchment
Amelia Parchment
CSChunhu Shi
Chunhu Shi
SDSchenelle Dayna Dlima
Schenelle Dayna Dlima
ESEmma Stanmore
Emma Stanmore
Background: Falls are common and costly among people living with Dementia (PLwD). Keep on Keep up (KOKU) is a UK National Health Service (NHS) approved tablet-based, digital gamified programme with strength and balance exercises and health literacy games, designed with and for older people at risk of falls. KOKU-LITE is a dementia-friendly accessible version of KOKU that has been co-developed with PLwD to meet their needs. This study aimed to assess the feasibility, usability and acceptability of KOKU-LITE among community dwelling PLwD in terms of recruitment, retention and user experience of the intervention. Methods: This is a two-arm, parallel, non-blinded, feasibility randomised controlled trial. Sixty people aged ≥55 years living with dementia were recruited across Greater Manchester, UK, and randomised to either intervention group (KOKU-LITE+ dementia falls prevention leaflet) or control group (dementia falls prevention leaflet). Intervention participants were asked to use KOKU-LITE for 30 minutes a day, three times/week for six weeks. Both groups were followed up to six weeks. Primary outcomes were feasibility, usability and acceptability assessed using recruitment and retention rates, and user experience measured by user experience questionnaire. Trial registration: https://clinicaltrials.gov/study/NCT06149702 . Findings: Sixty participants (30 intervention, 30 control) were recruited and followed up between March 2024 to September 2025. Among those approached, 87% (60/69) consented to participate, 90% (54/60) were retained at six weeks follow up. Overall, the user experience findings indicated strong acceptability and generally positive perceived usability and engagement. No serious adverse events, including injurious falls, were reported during the intervention period. Interpretation: KOKU-LITE was feasible to deliver and acceptable to PLwD in a home-based community setting. Although the study was not powered to assess effectiveness, the findings support progression to a definitive trial, with refinement of outcome selection, intervention-use monitoring and follow-up duration. Funding: National Institute for Health and Care Research (NIHR) and Alzheimer’s Society (Award number: NIHR200174).